Melanoma is the most severe and fatal form of skin cancer, resulting from multiple gene mutations with high intra-tumor and inter-tumor molecular heterogeneity. Treatment options for patients whose disease has progressed beyond the ability for surgical resection rely on currently accepted standard therapies, notably immune checkpoint inhibitors and targeted therapies. Acquired resistance to these therapies and treatment-associated toxicity necessitate exploring novel strategies, especially those that can be personalized for specific patients and/or populations. Here, we review the current landscape and progress of standard therapies and explore what personalized oncology techniques may entail in the scope of melanoma. Our purpose is to provide an up-to-date summary of the tools at our disposal that work to circumvent the common barriers faced when battling melanoma.
Melanoma , Precision Medicine , Skin Neoplasms , Humans , Melanoma/genetics , Melanoma/therapy , Melanoma/pathology , Precision Medicine/methods , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Skin Neoplasms/therapy , Molecular Targeted Therapy/methods , Immune Checkpoint Inhibitors/therapeutic use , Mutation
